Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.

Topol EJ, Bousser MG, Fox KA, Creager MA, Despres JP, Easton JD, Hamm CW, Montalescot G, Steg PG, Pearson TA, Cohen E, Gaudin C, Job B, Murphy JH, Bhatt DL; CRESCENDO Investigators.

Lancet. 2010 Aug 14;376(9740):517-23. doi: 10.1016/S0140-6736(10)60935-X.

PMID:
20709233
2.

Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study.

De Reuck J, Decoo D, Hasenbroekx MC, Lamont B, Santens P, Goethals P, Strijckmans K, Lemahieu I.

Eur Neurol. 1999 Jan;41(1):31-6.

PMID:
9885326

Supplemental Content

Loading ...
Write to the Help Desk